Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

ARNA
Arena Pharmaceuticals Inc
stock NASDAQ

Inactive
Mar 10, 2022
99.99USD+0.060%(+0.06)5,718,504
Pre-market
0.00USD-100.000%(-99.93)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 18, 2022
04:05PM EST  Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Jan 4, 2022
10:05PM EST  LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arena Pharmaceuticals, Inc. - ARNA   PR Newswire
Dec 21, 2021
10:14AM EST  Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2021   Benzinga
07:31AM EST  10 Biggest Price Target Changes For Tuesday   Benzinga
05:13AM EST  Cantor Fitzgerald Downgrades Arena Pharmaceuticals to Neutral, Raises Price Target to $100   Benzinga
Dec 17, 2021
04:16PM EST  The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More   Benzinga
Dec 14, 2021
11:25PM EST  LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arena Pharmaceuticals, Inc. - ARNA   PR Newswire
10:03AM EST  Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2021   Benzinga
09:59AM EST  What 6 Analyst Ratings Have To Say About Arena Pharmaceuticals   Benzinga
09:09AM EST  Citigroup Downgrades Arena Pharmaceuticals to Neutral, Lowers Price Target to $100   Benzinga
07:11AM EST  10 Biggest Price Target Changes For Tuesday   Benzinga
07:04AM EST  JMP Securities Downgrades Arena Pharmaceuticals to Market Perform   Benzinga
06:06AM EST  SVB Leerink Downgrades Arena Pharmaceuticals to Market Perform, Lowers Price Target to $100   Benzinga
05:42AM EST  RBC Capital Downgrades Arena Pharmaceuticals to Sector Perform, Raises Price Target to $100   Benzinga
05:41AM EST  Credit Suisse Downgrades Arena Pharmaceuticals to Neutral, Raises Price Target to $100   Benzinga
05:23AM EST  Jefferies Downgrades Arena Pharmaceuticals to Hold, Announces $100 Price Target   Benzinga
Dec 13, 2021
02:36PM EST  Mid-Afternoon Market Update: Dow Tumbles Over 200 Points; BELLUS Health Shares Spike Higher   Benzinga
01:08PM EST  Mid-Day Market Update: Nasdaq Drops Over 100 Points; Foghorn Therapeutics Shares Surge   Benzinga
12:34PM EST  Needham Downgrades Arena Pharmaceuticals to Hold   Benzinga
11:44AM EST  How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal   Benzinga
10:03AM EST  Mid-Morning Market Update: Markets Open Lower; Pfizer To Acquire Arena Pharmaceuticals   Benzinga
08:21AM EST  Top 10 WallStreetBets Stocks Premarket for Dec. 13, 2021: AAPL ,TSLA, GME, AMC, AMD, LCID, NVDA, UWMC, ARNA, MVIS   Benzinga
07:06AM EST  Pfizer Inc. (PFE) and Arena Pharmaceuticals, Inc. (ARNA) have entered into a definitive agreement under which Pfizer will acquire Arena. Pfizer will acquire all the outstanding shares of Arena for $100 per share in an all-cash deal for a total equity value of approximately $6.7 billion.   RTTNews
06:48AM EST  Pfizer To Buy Arena For $100/Shr Cash For Total Equity Value Of About $6.7 Bln   RTTNews
06:45AM EST  Pfizer to Acquire Arena Pharmaceuticals   Business Wire
06:21AM EST  Pfizer To Acquire Arena Pharmaceuticals For $100/Share In Cash   Benzinga
Dec 8, 2021
10:04AM EST  Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021   Benzinga
07:47AM EST  Wells Fargo Initiates Coverage On Arena Pharmaceuticals with Overweight Rating, Announces Price Target of $71   Benzinga
Nov 19, 2021
08:32AM EST  Arena Pharma Reports Achieved Target Enrollment For Etrasimod CULTIVATE Study A   Benzinga
Nov 5, 2021
09:32AM EDT  Arena Pharmaceuticals Q3 EPS $(3.21) Misses $(2.53) Estimate   Benzinga
Nov 4, 2021
05:22PM EDT  Arena Pharma Q3 Loss/share $3.21 Vs. Loss $1.69 Year Ago   RTTNews
08:19AM EDT  The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO   Benzinga
05:00AM EDT  Earnings Scheduled For November 4, 2021   Benzinga
Oct 31, 2021
02:24PM EDT  The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline   Benzinga
Aug 20, 2021
07:45AM EDT  The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data   Benzinga
Aug 19, 2021
10:57AM EDT  The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck   Benzinga
Aug 18, 2021
04:05PM EDT  Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
07:38AM EDT  The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline   Benzinga
Aug 17, 2021
08:28AM EDT  The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business   Benzinga
Aug 13, 2021
07:43AM EDT  The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO   Benzinga
Aug 12, 2021
08:09AM EDT  The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma   Benzinga
Aug 11, 2021
08:14AM EDT  The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering   Benzinga
Aug 10, 2021
10:42AM EDT  Cantor Fitzgerald Maintains Overweight on Arena Pharmaceuticals, Lowers Price Target to $93   Benzinga
07:55AM EDT  The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts   Benzinga
Aug 6, 2021
10:47AM EDT  Credit Suisse Maintains Outperform on Arena Pharmaceuticals, Lowers Price Target to $98   Benzinga
Aug 5, 2021
05:01PM EDT  Arena Pharma Q2 Loss/share $2.40 Vs. Loss $1.61 Year Ago   RTTNews
04:15PM EDT  Arena Pharmaceuticals Q2 EPS $(2.40) Misses $(2.19) Estimate   Benzinga
08:08AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO   Benzinga
07:25AM EDT  Second Genome And Arena Pharmaceuticals Announce Collaboration To 'Identify Gastrointestinal Biomarkers'; Financial Details Not Disclosed   Benzinga
07:07AM EDT  Second Genome, Arena Pharma Collaborate To Identify Gastrointestinal Biomarkers   RTTNews
07:01AM EDT  Second Genome Announces Collaboration with Arena Pharmaceuticals to Identify   PR Newswire
04:08AM EDT  Earnings Scheduled For August 5, 2021   Benzinga
Aug 4, 2021
07:52AM EDT  The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings   Benzinga
Aug 1, 2021
11:19AM EDT  The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs   Benzinga
Jul 28, 2021
07:33AM EDT  The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal   Benzinga
06:59AM EDT  Arena Pharma In-Licenses Aristea's CXCR2 Antagonist For Immune-Mediated Inflammatory Diseases   Benzinga
Jul 27, 2021
04:13PM EDT  Arena Pharma Reports Collaboration With Aristea Thearpeutics For Development Of RIST4721 For Treatment Of Serious Immune-Mediated inflammatory Diseases   Benzinga
Jul 1, 2021
05:54PM EDT  Sundial, MedMen And GrowGeneration Among Top Cannabis Stock Movers On July 1, 2021   Benzinga
Jun 25, 2021
05:24PM EDT  Cannabis Stock Gainers And Losers From June 25, 2021   Benzinga
Jun 8, 2021
06:01PM EDT  Arena Pharmaceuticals Granted Orphan Drug Designation For Treatment Of Eosinophilic Esophagitis   Benzinga
08:34AM EDT  Arena Pharmaceuticals Announces First Participant Randomized In Phase 2 Trial Evaluating Temanogrel In Coronary Microvascular Obstruction   Benzinga
May 18, 2021
10:05AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2021   Benzinga
06:52AM EDT  Goldman Sachs Initiates Coverage On Arena Pharmaceuticals with Buy Rating, Announces Price Target of $90   Benzinga
May 7, 2021
07:39AM EDT  SVB Leerink Maintains Outperform on Arena Pharmaceuticals, Raises Price Target to $112   Benzinga
May 5, 2021
04:51PM EDT  Arena Pharmaceuticals Q1 EPS $(1.98) Beats $(2.16) Estimate   Benzinga
07:43AM EDT  The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues   Benzinga
04:16AM EDT  Earnings Scheduled For May 5, 2021   Benzinga
Apr 27, 2021
10:06AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2021   Benzinga
06:57AM EDT  Citigroup Initiates Coverage On Arena Pharmaceuticals with Buy Rating, Announces Price Target of $104   Benzinga
Apr 23, 2021
10:11AM EDT  Arena Pharma Highlights Will Present Clinician, Patient Reported Outcomes Data From Phase 2b ADVISE Trial On Etrasimod In Adult Atopic Dermatitis During a Late-Breaking Session at American Academy of Dermatology VMX   Benzinga
07:28AM EDT  The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs   Benzinga
Apr 19, 2021
08:42AM EDT  Arena Pharmaceuticals To Present Data From Phase 2b ADVISE Trial During Late-Breaking Research Session At American Academy Of Dermatology Virtual Meeting Experience   Benzinga
Apr 13, 2021
08:07AM EDT  Credit Suisse Maintains Outperform on Arena Pharmaceuticals, Raises Price Target to $102   Benzinga
Mar 26, 2021
06:19AM EDT  HC Wainwright & Co. Maintains Buy on Arena Pharmaceuticals, Raises Price Target to $120   Benzinga
Mar 3, 2021
11:07AM EST  Return On Capital Employed Overview: Arena Pharmaceuticals   Benzinga
09:23AM EST  Cantor Fitzgerald Maintains Overweight on Arena Pharmaceuticals, Lowers Price Target to $100   Benzinga
07:46AM EST  The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study   Benzinga
06:10AM EST  Arena Pharma's Olorinab Fails To Top Placebo In IBS-Related Abdominal Pain   Benzinga
Mar 2, 2021
04:08PM EST  Arena Reports Topline Results From Phase 2b CAPTIVE Trial Showed Did Not Meet Primary Endpoint   Benzinga
Feb 24, 2021
05:24AM EST  SVB Leerink Maintains Outperform on Arena Pharmaceuticals, Lowers Price Target to $90   Benzinga
Feb 23, 2021
04:41PM EST  Recap: Arena Pharmaceuticals Q4 Earnings   Benzinga
04:15PM EST  Arena Pharmaceuticals Q4 EPS $(2.10) Misses $(1.85) Estimate   Benzinga
07:25AM EST  The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts   Benzinga
04:09AM EST  Earnings Scheduled For February 23, 2021   Benzinga
Feb 22, 2021
10:29AM EST  Arena Pharmaceuticals Earnings Preview   Benzinga
Feb 18, 2021
04:05PM EST  Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Feb 2, 2021
09:10AM EST  Arena Pharmaceuticals Completes Full Enrollment Of Etrasimod Phase 3 ELEVATE UC 52 Trial   Benzinga
Jan 29, 2021
05:14PM EST  Cannabis Stock Gainers And Losers From January 29, 2021   Benzinga
Jan 22, 2021
04:04PM EST  Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   Business Wire
Dec 22, 2020
04:01PM EST  Arena Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on   PR Newswire
Dec 18, 2020
01:02PM EST  Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule   PR Newswire
Dec 13, 2020
04:27PM EST  The Week Ahead In Biotech: 2 IPOs Plus FDA Decisions On Moderna's COVID Vaccine And Drugs From Amgen, MacroGenics   Benzinga
Dec 11, 2020
09:01AM EST  Arena Pharmaceuticals To Present Data From The Phase 2b ADVISE Trial - Late-Breaker   RTTNews
09:01AM EST  Arena Pharmaceuticals To Present Data From Phase 2b ADVISE Trial Late-Breaker At Revolutionizing Atopic Dermatitis Conference   Benzinga
09:01AM EST  Arena Pharmaceuticals to Present Data from the Phase 2b ADVISE Trial -   PR Newswire
Dec 8, 2020
08:40AM EST  Arena Pharma Says Achieves Target Enrollment For Etrasimod Phase 3 ELEVATE UC 52 Trial   RTTNews
08:32AM EST  Arena Pharmaceuticals Achieves Target Enrollment For Etrasimod Phase 4 ELEVATE UC 52 Trial   Benzinga
08:31AM EST  Arena Pharmaceuticals Achieves Target Enrollment for Etrasimod Phase 3 ELEVATE   PR Newswire
Nov 30, 2020
04:05PM EST  Arena Pharmaceuticals Announces R&D Leadership Transition   Business Wire
Nov 24, 2020
08:31AM EST  Arena Pharmaceuticals to Present at the Evercore ISI HealthCONx Conference on   PR Newswire
Nov 19, 2020
06:00PM EST  Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule   PR Newswire
09:41AM EST  Benzinga's Top Upgrades, Downgrades For November 19, 2020   Benzinga
05:39AM EST  SMBC Nikko Initiates Coverage On Arena Pharmaceuticals with Outperform Rating, Announces Price Target of $100   Benzinga
Nov 10, 2020
02:32PM EST  Mid-Afternoon Market Update: Dow Gains 200 Points; GasLog Partners Shares Slide Following Q3 Results   Benzinga
12:36PM EST  Mid-Day Market Update: Nasdaq Tumbles 200 Points; Greenland Technologies Shares Spike Higher   Benzinga
08:40AM EST  The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies   Benzinga
Nov 9, 2020
05:07PM EST  Arena Pharmaceuticals: Q3 Earnings Insights   Benzinga
04:37PM EST  Arena Pharmaceuticals Q3 EPS $(1.69) Beats $(1.87) Estimate, Sales $20.00K Down From $1.35M YoY   Benzinga
04:35PM EST  Shares of Arena Pharmaceuticals, Inc. (ARNA) plunged 20% in extended session Monday after it skin inflammation drug failed to meet primary endpoint in a mid-stage trial.   RTTNews
04:19PM EST  Arena Pharmaceuticals Advancing Etrasimod Into Phase 3 Program In Atopic Dermatitis (AD), Reports Compelling Topline Results From Phase 2b ADVISE Trial   Benzinga
04:09PM EST  Arena Pharmaceuticals Q3 Loss/share $1.69 Vs. Loss $.46 Year Ago   RTTNews
04:06PM EST  Advancing Etrasimod Into a Phase 3 Registrational Program in Atopic Dermatitis   PR Newswire
04:05PM EST  Arena Says Etrasimod Did Not Meet Ph 2b Primary Endpoint Of EASI Change From Baseline At Week 12   RTTNews
04:02PM EST  Dermatitis (AD), Reports Compelling Topline Results from Phase 2b ADVISE Trial   PR Newswire
04:13AM EST  Earnings Scheduled For November 9, 2020   Benzinga
Nov 8, 2020
03:58PM EST  The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions   Benzinga
12:47PM EST  The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs   Benzinga
Nov 6, 2020
10:18AM EST  Earnings Preview for Arena Pharmaceuticals   Benzinga
Nov 5, 2020
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
Nov 4, 2020
05:33PM EST  Cannabis Stock Gainers And Losers From November 4, 2020   Benzinga
Nov 2, 2020
08:31AM EST  Arena Pharmaceuticals to Release Third Quarter 2020 Financial Results and   PR Newswire
Oct 28, 2020
08:34AM EDT  Arena Pharmaceuticals Announces Launch Of Longboard Pharmaceuticals With $56M Financing   Benzinga
08:34AM EDT  Arena Pharma Announces Launch Of Longboard Pharmaceuticals With $56 Mln Financing   RTTNews
08:31AM EDT  Arena Pharmaceuticals Announces Launch of Longboard Pharmaceuticals With $56M   PR Newswire
Oct 20, 2020
04:04PM EDT  Arena Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)   RTTNews
04:01PM EDT  Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule   PR Newswire
Oct 9, 2020
04:30PM EDT  Arena Pharmaceuticals' Presence at United European Gastroenterology Week   PR Newswire
Oct 1, 2020
08:39AM EDT  Arena Pharmaceuticals Completes Full Enrollment Of Its Olorinab Phase 2 CAPTIVATE Trial For The Abdominal Pain In Irritable Bowel Syndrome   Benzinga
08:32AM EDT  Arena Completes Full Enrollment Of Phase 2b CAPTIVATE Trial Evaluating Olorinab   RTTNews
08:31AM EDT  Arena Pharmaceuticals Completes Full Enrollment of Olorinab Phase 2 CAPTIVATE   PR Newswire
Sep 30, 2020
10:34AM EDT  B of A Securities Maintains Buy on Arena Pharmaceuticals, Raises Price Target to $85   Benzinga
Sep 18, 2020
04:01PM EDT  Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule   PR Newswire
09:01AM EDT  Arena Pharmaceuticals to Present at the Jefferies Virtual Next Generation IBD   PR Newswire
Sep 16, 2020
08:33AM EDT  Arena Pharma Announces First Subject Dosed In ELEVATE UC 12 Global Phase 3 Trial Of Etrasimod In Ulcerative Colitis   RTTNews
08:32AM EDT  Arena Pharmaceuticals Announces First Subject Dosed In ELEVATE UC 12 Global Phase 3 Trial Evaluating Etrasimod In Ulcerative Colitis   Benzinga
08:31AM EDT  Arena Pharmaceuticals Announces First Subject Dosed in ELEVATE UC 12 Global   PR Newswire
Sep 3, 2020
04:01PM EDT  Arena Pharmaceuticals to Participate in Upcoming Investor Conferences   PR Newswire
Sep 2, 2020
01:41PM EDT  The Pure US Cannabis ETF Started Trading Today: Here Are Its Holdings   Benzinga
Sep 1, 2020
08:39AM EDT  Arena Pharmaceuticals Announces First Subject Dosed In Phase 2 Trial Evaluating Etrasimod In Alopecia Areata   Benzinga
08:32AM EDT  Arena Says First Subject Dosed In Phase 2 Trial Evaluating Etrasimod In Alopecia Areata   RTTNews
08:31AM EDT  Arena Pharmaceuticals Announces First Subject Dosed in Phase 2 Trial Evaluating   PR Newswire
Aug 19, 2020
04:01PM EDT  Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule   PR Newswire
Aug 6, 2020
02:07PM EDT  Wells Fargo Maintains Overweight on Arena Pharmaceuticals, Raises Price Target to $78   Benzinga
05:09AM EDT  SVB Leerink Maintains Outperform on Arena Pharmaceuticals, Raises Price Target to $91   Benzinga
Aug 5, 2020
04:15PM EDT  Arena Pharmaceuticals Q2 EPS $(1.61) Beats $(2.03) Estimate   Benzinga
04:04PM EDT  Arena Q2 Loss/Shr $$1.61 Vs Loss $1.24 Last Year   RTTNews
04:02PM EDT  Arena Reports Second Quarter Financial Results with Strong Liquidity Position,   PR Newswire
04:21AM EDT  Earnings Scheduled For August 5, 2020   Benzinga
Jul 29, 2020
04:01PM EDT  Arena Pharmaceuticals to Release Second Quarter 2020 Financial Results and   PR Newswire
Jul 27, 2020
06:56AM EDT  Citigroup Maintains Buy on Arena Pharmaceuticals, Raises Price Target to $83   Benzinga
Jul 17, 2020
04:01PM EDT  Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule   PR Newswire
Jul 14, 2020
05:12PM EDT  Cannabis Stock Gainers And Losers From July 14, 2020   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC